| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/2011 | CA2418784C Use of compounds derived from the genus euphorbia for the treatment of carcinoma of the bladder |
| 03/29/2011 | CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof |
| 03/29/2011 | CA2410968C Method of treating chronic ulcers |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/29/2011 | CA2387611C Manufacture of polyglutamate-therapeutic agent conjugates |
| 03/29/2011 | CA2383779C N-(indolecarbonyl)piperazine derivatives |
| 03/29/2011 | CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 03/29/2011 | CA2379508C Biphasic skin composition comprising ascorbic acid, ceramides and betaglycane |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
| 03/29/2011 | CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 03/29/2011 | CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/25/2011 | CA2680647A1 Preparations of taxanes for intravenous administration and the preparation method thereof |
| 03/24/2011 | WO2011035332A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators |
| 03/24/2011 | WO2011035324A1 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators |
| 03/24/2011 | WO2011035314A2 Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states |
| 03/24/2011 | WO2011035305A1 Compositions and methods for treating bacterial infections using ceftaroline |
| 03/24/2011 | WO2011035288A1 Dicyclanil-based aqueous suspension and non-aqueous solution pour-on and spray on formulations for the prevention and treatment of insect infestation in animal |
| 03/24/2011 | WO2011035274A1 Use of the sparc microenvironment signature in the treatment of cancer |
| 03/24/2011 | WO2011035239A1 Kcnq1 and kcne2 in thyroid disease |
| 03/24/2011 | WO2011035225A1 Synergistic combination therapy |
| 03/24/2011 | WO2011035214A1 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | WO2011035212A2 Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury |
| 03/24/2011 | WO2011035209A1 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | WO2011035186A1 Substituted heteroarylamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | WO2011035179A1 Method of slowing the aging process by activating sirtuin enzymes with a combination of fucoxanthin and punicic acid |
| 03/24/2011 | WO2011035174A1 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 03/24/2011 | WO2011035161A1 Process for the synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5'7'-tetraiodo-3h-spiro[isobenzofuran-1,9'-xanthen]-3-one (rose bengal) and related xanthenes |
| 03/24/2011 | WO2011035158A2 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 03/24/2011 | WO2011035143A2 Methods and compositions for inhibiting rho-mediated diseases and conditions |
| 03/24/2011 | WO2011035142A1 Use of opioid receptor antagonist for gastrointestinal tract disorders |
| 03/24/2011 | WO2011035124A1 Benzodiazepinone compounds and methods of treatment using same |
| 03/24/2011 | WO2011035120A2 Therapeutic composition to treat lesions caused by herpes simplex virus |
| 03/24/2011 | WO2011035110A2 Treatment for oxidative stress and/or hypertension |
| 03/24/2011 | WO2011035077A1 Novel compounds and therapeutic use thereof for protein kinase inhibition |
| 03/24/2011 | WO2011035031A1 Bisphosphonate-prostatic acid phosphatase inhibitor conjugates to treat prostate cancer bone metastasis |
| 03/24/2011 | WO2011035022A1 Tricyclic compounds and pharmaceutical uses thereof |
| 03/24/2011 | WO2011035009A1 Heterocyclic gtp cyclohydrolase 1 inhibitors for the treatment of pain |
| 03/24/2011 | WO2011035005A2 Compositions and methods for reducing the risk of agent-induced liver toxicity |
| 03/24/2011 | WO2011034971A1 Modified fluoroquinolone compounds and methods of using the same |
| 03/24/2011 | WO2011034962A2 Compounds that modulate intracellular calcium |
| 03/24/2011 | WO2011034951A2 Assisted enzyme replacement therapy |
| 03/24/2011 | WO2011034934A1 Abt-263 crystalline forms and solvates for use in treating bcl-2 protein related diseases |
| 03/24/2011 | WO2011034920A1 Compositions and methods for treating seizure disorders |
| 03/24/2011 | WO2011034919A2 Sh2 domain profiling to characterize tyrosine phosphorylation signaling in cancer |
| 03/24/2011 | WO2011034915A1 Compositions and methods for treating disorders of gastrointestinal motility |
| 03/24/2011 | WO2011034912A1 Compositions and methods for treating spasticity |
| 03/24/2011 | WO2011034907A2 Protein kinase conjugates and inhibitors |
| 03/24/2011 | WO2011034896A2 Small molecule inhibitors of the alpha4-paxillin interaction |
| 03/24/2011 | WO2011034887A2 A method for treating neuropathic pain |
| 03/24/2011 | WO2011034834A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 03/24/2011 | WO2011034832A1 Substituted phenoxymethyl dihydro oxazolopyrimidinones, preparation and use thereof |
| 03/24/2011 | WO2011034830A1 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof |
| 03/24/2011 | WO2011034828A1 Substituted para-biphenyloxymethyl dihydro oxazolopyrimidinones, preparation and use thereof |
| 03/24/2011 | WO2011034772A1 Na/k-atpase ligands, ouabain antagonists, assays and uses thereof |
| 03/24/2011 | WO2011034743A1 Preparation of crystalline forms of dihydropyrazolopyrimidinone |
| 03/24/2011 | WO2011034741A1 Imidazopyridin-2-one derivatives |
| 03/24/2011 | WO2011034630A1 Keratinous bonding matrices |
| 03/24/2011 | WO2011034583A2 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | WO2011034554A1 A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti -inflammatory drug |
| 03/24/2011 | WO2011034532A1 Stilbene-based compositions and methods of use therefor |
| 03/24/2011 | WO2011034518A1 Hcv protease inhibitors |
| 03/24/2011 | WO2011034513A1 The granules with improved solubility and stability |
| 03/24/2011 | WO2011034504A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same |
| 03/24/2011 | WO2011034465A1 A pharmaceutical composition for peroral administration of diindolylmethane |
| 03/24/2011 | WO2011034462A1 Combined anti-tuberculosis preparation |
| 03/24/2011 | WO2011034421A1 Fra-1 target genes as drug targets for treating cancer |
| 03/24/2011 | WO2011034396A2 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion |
| 03/24/2011 | WO2011034362A9 Composition containing saururus chinensis extract or sauchinone as an active ingredient, for preventing and treating diseases caused by the overexpression of lxr-α |
| 03/24/2011 | WO2011034362A2 Composition containing saururus chinensis extract or sauchinone as an active ingredient, for preventing and treating diseases caused by the overexpression of lxr-α |
| 03/24/2011 | WO2011034328A2 Composition including chlorophyll a as an active ingredient for preventing and treating th2-mediated immunological diseases |
| 03/24/2011 | WO2011034274A2 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034210A1 Pharmaceutical combination for treating tumor |
| 03/24/2011 | WO2011034192A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011034051A1 Novel cyclic squaramide derivatives |
| 03/24/2011 | WO2011034006A1 Composition for lowering blood uric acid level |
| 03/24/2011 | WO2011033884A1 Prophylactic agent for muscular contracture |
| 03/24/2011 | WO2011033717A1 Goya koji composition |
| 03/24/2011 | WO2011033715A1 External preparation for skin |
| 03/24/2011 | WO2011033531A1 A reusable end-capped bipyridine compound useful for selective detection of cyanide anions and process for preparation thereof |
| 03/24/2011 | WO2011033518A1 Sulfanylamide derivatives, uses thereof and compositions comprising them |
| 03/24/2011 | WO2011033470A1 Crystalline form of montelukast sodium |
| 03/24/2011 | WO2011033356A1 Pharmaceutical composition for reducing weight and method for the production thereof |
| 03/24/2011 | WO2011033306A1 Inhibition of tendon adhesions |
| 03/24/2011 | WO2011033305A1 Mannose 6-phosphate for use in promoting peripheral nerve function after injury |
| 03/24/2011 | WO2011033304A1 Improvement of tendon repair |
| 03/24/2011 | WO2011033265A1 Pharmaceutical compounds |
| 03/24/2011 | WO2011033255A1 (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use |
| 03/24/2011 | WO2011033230A1 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof |
| 03/24/2011 | WO2011033229A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033225A2 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033207A1 Cosmetic composition including leucodopachrome derivative |
| 03/24/2011 | WO2011033099A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia |
| 03/24/2011 | WO2011033094A1 Schedule of administration of benzazole derivatives in the treatment of leukemias |